GlassScriptPhysician profile
Orville I Hendricks
NPI 1700889573
$22,356.35
in general payments reported to CMS, 2019-2025
63 companies · $3,416 in 2025
The $3,416 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,257 · 2020: $2,459 · 2021: $3,390 · 2022: $3,005 · 2023: $3,513 · 2024: $3,317 · 2025: $3,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $29.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,216.97 |
| Education | $29.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,053.39 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Abbvie INC. | $1,829.02 | 2019-2025 | |
| Lilly USA, LLC | $1,827.31 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,809.60 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $1,554.66 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,391.28 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $1,279.22 | 2019-2025 | |
| Amgen INC. | $1,018.34 | 2019-2025 | Otezla, Repatha, Repatha |
| Astellas Pharma US INC | $718.59 | 2019-2024 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $626.82 | 2019-2025 | |
| Corcept Therapeutics | $603.22 | 2024-2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $550.62 | 2019-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $543.31 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $505.74 | 2019-2025 | Verquvo, Belsomra, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $497.55 | 2021-2025 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $480.35 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $479.46 | 2019-2025 | |
| Abbott Laboratories | $456.59 | 2020-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $431.14 | 2019-2023 | |
| Mannkind Corporation | $405.15 | 2020-2023 | Afrezza |
| Kowa Pharmaceuticals America, INC. | $349.28 | 2019-2023 | Seglentis |
| Takeda Pharmaceuticals U.S.A., INC. | $347.11 | 2019-2023 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $278.97 | 2019-2025 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $168.35 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $166.15 | 2024 | Optimizer |
| Daiichi Sankyo INC. | $155.09 | 2019-2023 | Injectafer |
| Axsome Therapeutics, INC. | $120.53 | 2023-2025 | Auvelity |
| Allergan, INC. | $120.29 | 2020 | |
| Insulet Corporation | $113.95 | 2024-2025 | Omnipod |
| Baxter Healthcare | $111.71 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Eisai INC. | $103.40 | 2019-2022 | |
| Shield Therapeutics INC | $95.71 | 2023-2024 | Accrufer |
| Currax Pharmaceuticals LLC | $81.46 | 2021-2023 | Onzetra Xsail, Contrave |
| Gilead Sciences, INC. | $79.84 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $77.05 | 2024-2025 | Gemtesa |
| Grifols USA, LLC | $73.78 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $58.99 | 2022 | |
| Bausch Health US, LLC | $55.29 | 2021-2025 | Aplenzin |
| Idorsia Pharmaceuticals US INC | $50.90 | 2022-2023 | Quviviq |
| Genentech USA, INC. | $47.53 | 2019 | |
| Sanofi Pasteur INC. | $46.57 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $42.77 | 2019 | |
| Optinose US, INC. | $42.42 | 2021-2025 | |
| Scilex Pharmaceuticals INC. | $41.14 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $36.56 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $36.14 | 2023-2024 | Unithroid |
| Edwards Lifesciences Corporation | $36.05 | 2022-2024 | Sapien 3 Ultra Resilia |
| Dermira, INC. | $34.61 | 2020 | |
| Dexcom, INC. | $32.68 | 2023-2024 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $32.60 | 2024 | Licart, Tirosint, Flector |
| Endo Pharmaceuticals INC. | $28.00 | 2019 | |
| Biotronik INC. | $26.50 | 2023 | Acticor 7 Vr-T Dx, Edora 8 Dr-T |
| Impel Pharmaceuticals INC. | $24.00 | 2022 | |
| Seqirus USA INC | $23.58 | 2025 | Fluad, Flucelvax |
| Inspire Medical Systems, INC. | $22.23 | 2024 | Inspire |
| Vbi Vaccine (Delaware) INC. | $22.21 | 2023 | Prehevbrio |
| Paratek Pharmaceuticals, INC. | $18.42 | 2022 | |
| Upsher-Smith Laboratories LLC | $17.95 | 2021 | |
| Phathom Pharmaceuticals, INC. | $16.32 | 2023 | Voquezna |
| Hikma Pharmaceuticals USA | $15.66 | 2023 | Ryaltris |
| Bardy Diagnostics, INC. | $15.25 | 2022 | |
| Lundbeck LLC | $14.09 | 2025 | Rexulti |
| Ironwood Pharmaceuticals, INC | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orville Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.